Pharmaceutical Industry is the biggest beneficiary of the Bioinformatics / Pharmaco-Informatics revolution arising out of Post-genomic endeavors and computing advancements. With the accomplishment of the Human Genome Project, the deluge of its derived information imposes an unprecedented impact on all fields of biology and medicine. We are now moving into an era where drugs may be designed as per individual genetic profiles. It has been found that pharmaceutical companies can simultaneously save many hundred million dollars and years in new drug design and introduction by integrating data and information across disciplines, pharmaceutical departments, processes and drugs.

The field of pharmacoinformatics is emerging as a new discipline as a result of the integration of bioinformatics, Cheminformatics, chemogenomics, in silico ADME/T methods, pharmacy informatics etc. especially catering to the needs of the pharmaceutical sciences by providing the scientific and technical tools, for target specific drug design & development